John K. Bakewell, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), bought 130,000 shares at $4.57 ($594K) on 2024-05-10, disclosed to the SEC on 2024-05-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| WMGI | SELL | 2009-05-19 | $18K | — | Filing → |
| WMGI | SELL | 2009-05-15 | $8K | — | Filing → |
| WMGI | SELL | 2007-05-08 | $4.2M | — | Filing → |